{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:06:57Z","timestamp":1794344817664,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471271"],"award-info":[{"award-number":["82471271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971689"],"award-info":[{"award-number":["81971689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23492-8","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T07:58:02Z","timestamp":1757663882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["The global, regional, and National burden of parkinson\u2019s disease in 204 countries and territories, 1990\u20132021: a systematic analysis for the global burden of disease study 2021"],"prefix":"10.1186","volume":"25","author":[{"given":"Yaqiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuzhenxiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"issue":"10423","key":"23492_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, et al. The pathogenesis of parkinson\u2019s disease. Lancet. 2024;403(10423):293\u2013304.","journal-title":"Lancet"},{"issue":"5","key":"23492_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, et al. Challenges in the diagnosis of parkinson\u2019s disease. Lancet Neurol. 2021;20(5):385\u201397.","journal-title":"Lancet Neurol"},{"issue":"6","key":"23492_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: A review. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"issue":"10423","key":"23492_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, et al. The epidemiology of parkinson\u2019s disease. Lancet. 2024;403(10423):283\u201392.","journal-title":"Lancet"},{"issue":"11","key":"23492_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"regional Global","year":"2018","unstructured":"Global regional. National burden of parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"issue":"10258","key":"23492_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Global burden","year":"2020","unstructured":"Global burden. Of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"10440","key":"23492_CR7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10440","key":"23492_CR8","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 sub-national locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2100\u201332.","journal-title":"Lancet"},{"issue":"10159","key":"23492_CR9","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and National incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"issue":"8","key":"23492_CR10","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3233\/JPD-223363","volume":"12","author":"C Coleman","year":"2022","unstructured":"Coleman C, Martin I. Unraveling parkinson\u2019s disease neurodegeneration: does aging hold the clues?? J Parkinsons Dis. 2022;12(8):2321\u201338.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"23492_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7(1):47.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"23492_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1474-4422(16)00060-0","volume":"15","author":"D Salat","year":"2016","unstructured":"Salat D, Noyce AJ, Schrag A, Tolosa E. Challenges of modifying disease progression in prediagnostic parkinson\u2019s disease. Lancet Neurol. 2016;15(6):637\u201348.","journal-title":"Lancet Neurol"},{"issue":"12","key":"23492_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257\u201372.","journal-title":"Lancet Neurol"},{"issue":"1","key":"23492_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/mds.24997","volume":"28","author":"AE Lang","year":"2013","unstructured":"Lang AE, Melamed E, Poewe W, Rascol O. Trial designs used to study neuroprotective therapy in parkinson\u2019s disease. Mov Disord. 2013;28(1):86\u201395.","journal-title":"Mov Disord"},{"issue":"22","key":"23492_CR15","first-page":"2035","volume":"80","author":"G Pezzoli","year":"2013","unstructured":"Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson. Disease Neurol. 2013;80(22):2035\u201341.","journal-title":"Disease Neurol"},{"issue":"6","key":"23492_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1212\/WNL.0000000000002254","volume":"86","author":"RD Abbott","year":"2016","unstructured":"Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, et al. Midlife milk consumption and substantia Nigra neuron density at death. Neurology. 2016;86(6):512\u20139.","journal-title":"Neurology"},{"issue":"1","key":"23492_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.21535","volume":"65","author":"X Gao","year":"2009","unstructured":"Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Genetic determinants of hair color and parkinson\u2019s disease risk. Ann Neurol. 2009;65(1):76\u201382.","journal-title":"Ann Neurol"},{"issue":"9","key":"23492_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1002\/mds.25458","volume":"28","author":"S Jafari","year":"2013","unstructured":"Jafari S, Etminan M, Aminzadeh F, Samii A. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013;28(9):1222\u20139.","journal-title":"Mov Disord"},{"issue":"8","key":"23492_CR19","doi-asserted-by":"publisher","first-page":"e209201","DOI":"10.1212\/WNL.0000000000209201","volume":"102","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Lai Y, Konijnenberg H, et al. Association of coffee consumption and prediagnostic caffeine metabolites with incident Parkinson disease in a Population-Based cohort. Neurology. 2024;102(8):e209201.","journal-title":"Neurology"},{"key":"23492_CR20","doi-asserted-by":"publisher","first-page":"102381","DOI":"10.1016\/j.arr.2024.102381","volume":"99","author":"Y Yang","year":"2024","unstructured":"Yang Y, Zhou ZD, Yi L, et al. Interaction between caffeine consumption & genetic susceptibility in parkinson\u2019s disease: A systematic review. Ageing Res Rev. 2024;99:102381.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"23492_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ana.24281","volume":"76","author":"KC Simon","year":"2014","unstructured":"Simon KC, Eberly S, Gao X, et al. Mendelian randomization of serum urate and Parkinson disease progression. Ann Neurol. 2014;76(6):862\u20138.","journal-title":"Ann Neurol"},{"issue":"11","key":"23492_CR22","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/jnnp-2023-332974","volume":"95","author":"M Langeskov-Christensen","year":"2024","unstructured":"Langeskov-Christensen M, Hvid L, et al. Exercise as medicine in parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2024;95(11):1077\u201388.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"16","key":"23492_CR23","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1212\/WNL.0000000000000879","volume":"83","author":"B Ritz","year":"2014","unstructured":"Ritz B, Lee PC, Lassen CF, et al. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease. Neurology. 2014;83(16):1396\u2013402.","journal-title":"Neurology"},{"issue":"10440","key":"23492_CR24","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"Burden of disease scenarios","year":"2024","unstructured":"Burden of disease scenarios. For 204 countries and territories, 2022\u20132050: a forecasting analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2204\u201356.","journal-title":"Lancet"},{"issue":"100","key":"23492_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D. Ageing and parkinson\u2019s disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14(100):19\u201330.","journal-title":"Ageing Res Rev"},{"key":"23492_CR26","doi-asserted-by":"crossref","unstructured":"Yang Q, Chang X, Li S, Li X, Kang C, Yuan W, Lv G. Disease Burden of Parkinson\u2019s Disease in Asia and Its 34 Countries and Territories from 1990 to 2021: Findings from the Global Burden of Disease Study 2021. Neuroepidemiology. 2024 Nov;14:1\u201333.","DOI":"10.1159\/000542606"},{"key":"23492_CR27","doi-asserted-by":"crossref","unstructured":"Zhang J, Fan Y, Liang H, Zhang Y. Global, regional and national temporal trends in Parkinson\u2019s disease incidence, disability-adjusted life year rates in middle-aged and older adults: a cross-national inequality analysis and Bayesian age-period-cohort analysis based on the global burden of disease 2021. Neurol Sci. 2024 Dec 14.","DOI":"10.1007\/s10072-024-07941-7"},{"key":"23492_CR28","first-page":"101078","volume":"8","author":"T Xu","year":"2024","unstructured":"Xu T, Dong W, Liu J, Yin P, Wang Z, Zhang L, Zhou M. Disease burden of parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021. Lancet Reg Health West Pac. 2024;8:46:101078.","journal-title":"Lancet Reg Health West Pac"},{"issue":"10062","key":"23492_CR29","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, et al. (The GATHER working Group). Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016;388(10062):e19\u201323.","journal-title":"Lancet"},{"issue":"9963","key":"23492_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and National age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117\u201371.","journal-title":"Lancet"},{"issue":"3","key":"23492_CR31","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1212\/WNL.0000000000013115","volume":"98","author":"Q Ding","year":"2022","unstructured":"Ding Q, Liu S, Yao Y, Liu H, Cai T, Han L. Global, regional, and National burden of ischemic stroke, 1990\u20132019. Neurology. 2022;98(3):e279\u201390.","journal-title":"Neurology"},{"issue":"8","key":"23492_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamapediatrics.2023.2029","volume":"177","author":"K Zhang","year":"2023","unstructured":"Zhang K, Kan C, Han F, et al. Global, regional, and National epidemiology of diabetes in children from 1990 to 2019. JAMA Pediatr. 2023;177(8):837\u2013837.","journal-title":"JAMA Pediatr"},{"issue":"Suppl 1","key":"23492_CR33","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0140-6736(22)02247-4","volume":"400","author":"HME Foster","year":"2022","unstructured":"Foster HME, Gill JMR, Jani BD, et al. Associations between a weighted health behaviour score, socioeconomic status, and all-cause mortality in UK biobank cohort: a prospective analysis. Lancet. 2022;400(Suppl 1):S37.","journal-title":"Lancet"},{"issue":"13","key":"23492_CR34","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2021.15187","volume":"326","author":"J He","year":"2021","unstructured":"He J, Zhu Z, Bundy JD, et al. Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999\u20132018. JAMA. 2021;326(13):1286\u201398.","journal-title":"JAMA"},{"key":"23492_CR35","doi-asserted-by":"publisher","first-page":"113972","DOI":"10.1016\/j.ecoenv.2022.113972","volume":"243","author":"B Vellingiri","year":"2022","unstructured":"Vellingiri B, Chandrasekhar M, Sri Sabari S, et al. Neurotoxicity of pesticides - A link to neurodegeneration. Ecotoxicol Environ Saf. 2022;243:113972.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"2","key":"23492_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JPD-225047","volume":"13","author":"ER Dorsey","year":"2023","unstructured":"Dorsey ER, Zafar M, Lettenberger SE, et al. Trichloroethylene: an invisible cause of parkinson\u2019s disease?? J Parkinsons Dis. 2023;13(2):203\u201318.","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"23492_CR37","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1007\/s00415-022-11282-w","volume":"269","author":"B Vellingiri","year":"2022","unstructured":"Vellingiri B, Suriyanarayanan A, Abraham KS, et al. Influence of heavy metals in parkinson\u2019s disease: an overview. J Neurol. 2022;269(11):5798\u2013811.","journal-title":"J Neurol"},{"issue":"3","key":"23492_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10654-017-0229-z","volume":"32","author":"S Kab","year":"2017","unstructured":"Kab S, Spinosi J, Chaperon L, et al. Agricultural activities and the incidence of parkinson\u2019s disease in the general French population. Eur J Epidemiol. 2017;32(3):203\u201316.","journal-title":"Eur J Epidemiol"},{"issue":"22","key":"23492_CR39","doi-asserted-by":"publisher","first-page":"e2106","DOI":"10.1212\/WNL.0000000000006565","volume":"91","author":"S Karceski","year":"2018","unstructured":"Karceski S. Parkinson disease and mortality: Understanding how the two are connected. Neurology. 2018;91(22):e2106\u20138.","journal-title":"Neurology"},{"issue":"11","key":"23492_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"23492_CR41","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and parkinson\u2019s disease. Environ Health Perspect. 2011;119(6):866\u201372.","journal-title":"Environ Health Perspect"},{"key":"23492_CR42","doi-asserted-by":"crossref","unstructured":"Incidence of Parkinson\u2019s disease in Germany based on prevalence data from 70 million patients of the statutory health insurance. BMC Neurol. 2024;24 (1):221.","DOI":"10.1186\/s12883-024-03739-4"},{"issue":"2","key":"23492_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ncl.2022.12.001","volume":"41","author":"R Patel","year":"2023","unstructured":"Patel R, Kompoliti K. Sex and gender differences in parkinson\u2019s disease. Neurol Clin. 2023;41(2):371\u20139.","journal-title":"Neurol Clin"},{"issue":"3","key":"23492_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F. Parkinson\u2019s disease in women and men: what\u2019s the difference?? J Parkinsons Dis. 2019;9(3):501\u201315.","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"23492_CR45","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/mds.20117","volume":"19","author":"G Alves","year":"2004","unstructured":"Alves G, Kurz M, Lie SA, et al. Cigarette smoking in parkinson\u2019s disease: influence on disease progression. Mov Disord. 2004;19(9):1087\u201392.","journal-title":"Mov Disord"},{"issue":"1","key":"23492_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/mds.27063","volume":"33","author":"A Rossi","year":"2018","unstructured":"Rossi A, Berger K, Chen H, et al. Projection of the prevalence of parkinson\u2019s disease in the coming decades: revisited. Mov Disord. 2018;33(1):156\u20139.","journal-title":"Mov Disord"},{"issue":"7","key":"23492_CR47","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/archneurol.2010.135","volume":"67","author":"R Savica","year":"2010","unstructured":"Savica R, Rocca WA, Ahlskog JE. When does Parkinson disease start? Arch Neurol. 2010;67(7):798\u201380.","journal-title":"Arch Neurol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23492-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T09:02:56Z","timestamp":1757667776000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23492-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23492"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23492-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research adhered to the ethical guidelines established by the governing authority of the 2021 Global Burden of Disease database. Since the study utilized publicly accessible, de-identified data, it did not necessitate further ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study utilized data from publicly available databases, which do not contain identifiable personal information. Therefore, consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3047"}}